Objectives To compare the impact of clomiphene citrate (CC) vs other drug regimens on mid-cycle endometrial thickness (EMT), ovulation, pregnancy and live birth rates in women with World Health Organization (WHO) group II ovulatory disorders.
Methods (1957 women, 3892 cycles; RR, 0.78; 95% CI, 0.63-0.95; I 2 = 43%) and a lower live birth rate (RR, 0.70; 95% CI,